Lincomycin derivatives are a small group of antibiotics that inhibit synthesis of bacterial proteins, essential for bacteria to survive. Lincomycin derivatives are reserved for treatment of infections due to susceptible strains of pneumococci, staphylococci and streptococci. One derivative is also indicated for treatment of Plasmodium falciparum (malaria).
Name | Updated |
---|---|
Lincomycin (Lincomycin [ lin-koe-mye-sin ]) | 14-Aug-2023 |
Lincocin (Lincomycin [ lin-koe-mye-sin ]) | 05-Aug-2023 |
Cleocin (Clindamycin [ klin-da-mye-sin ]) | 13-Jul-2023 |
Clindamycin (Clindamycin (oral/injection) [ klin-da-mye-sin ]) | 10-Jul-2023 |